CeNeS Pharmaceuticals Plc has appointed Tony Osborne as finance director and also a member of the company’s Board of Directors. Mr Osborne is a chartered accountant with 13 years of experience in the biotechnology industry. He was previously financial controller at Cobra Therapeutics, formerly Therexsys.
CeNeS is based in Cambridge UK and specialises in the development and commercialisation of drugs for pain control, sedation and central nervous system disorders.
Source:
CeNeS Pharmaceuticals press release, 12 November 2007
Copyright 2007 Evernow Publishing Ltd